Sharechat Logo

CANGO Press Release | Pharmac Funding

Tuesday 30th April 2024

Text too small?

Source: Prostate Cancer Foundation 

--

Associate Health Minister David Seymour’s announcement of an additional $1.774, to address Pharmac’s deficit over the next 4 years is a good first step to ensure Kiwi’s continue to have access to existing funded medicines.

Although this is Pharmac’s biggest budget ever, significantly more is needed; as incremental change will not address medicines currently sitting on the options for funding list, considered standard of care in other countries or New Zealand sitting at the bottom of the OCED for medicine access.

We remain hopeful that the additional investment in Pharmac’s budget is only the first step in the Minister Seymour’s commitment to the transformational change that New Zealanders need, to ensure access to life saving pharmaceuticals.

About CANGO: CANGO (Cancer Non-Governmental Organisations) is an alliance of prominent New Zealand cancer charities including:

• Breast Cancer Foundation NZ 

• Bowel Cancer New Zealand 

• Cancer Societ of New Zealand 

• Gut Cancer Foundation 

• Ovarian Cancer Foundation 

• Leukaemia & Blood Cancer New Zealand 

• Melanoma New Zealand 

• Prostate Cancer Foundation of New Zealand 

• Unicorn Foundation of New Zealand 

The group was formed in 2007 in an effort to increase collaboration among cancer charities.Chief Executives of member organisations meet quarterly to discuss key issues facing the sector; to meet and share information with representatives from Te Aho o Te Kahu, the Ministry of Health and others working in cancer related areas; and to work together on specific initiatives that reflect the shared goal of all members to reduce the incidence and impact of cancer on New Zealand and New Zealanders.

ENDS

For more information contact:
Ah-Leen Rayner 
Chief Executive, Breast Cancer Foundation NZ 
Current Chair, CANGO
Email: ahleenr@bcf.org.nz Mobile: +64 2191 6454



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

PaySauce Quarterly Market Update - June 2024
Manawa Energy - Annual Meeting and Director Nominations
SKO - Annual Shareholders Meeting Materials
VGL - 2024 Half Year Results Announcement Date
TruScreen Group Limited ("TRU") - Late Annual Report
ARB - Sale of In Vitro Business
NZK - Change of External Auditor
SCT - Scott lands major contracts for MHL in Europe
July 2nd Morning Report
PFI - Details of FP24 Results Webcast